Endoplasmic reticulum stress
Human evidence and registered trials are visible in this field
3 human-evidence records · 0 active trials · 6 visible funding records · 6,830 universities
Longevity Patent Family
METHODS OF TREATING AGING-RELATED DISEASES AND DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING, PROTEIN AGGREGATION, OR ENDOPLASMIC RETICULUM STRESS
Source-linked patent metadata for METHODS OF TREATING AGING-RELATED DISEASES AND DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING, PROTEIN AGGREGATION, OR ENDOPLASMIC RETICULUM STRESS, including priority, record stage and longevity-topic connections.
Patent-family snapshot
Application publication visible
Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.
- Representative publication
- WO2025128707A1
- Earliest priority
- December 11, 2023
- Latest publication
- June 19, 2025
- Family publications
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Proteostasis
Human evidence is visible; an active trial pathway is not yet visible
2 human-evidence records · 0 active trials · 62 visible funding records · 6,089 universities
Organizations named in this family
Topics connected by metadata
Endoplasmic reticulum stress88% metadata match
Proteostasis88% metadata match
What this family cites
- Earlier patent references
- 0
- Scientific and other non-patent references
- 0
- Priority dates represented
- 2
References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.
How the patent office classifies this invention
No patent classification is available in the retained record.
Verify in the original patent source →